Applied Genetic Technologies (AGTC) Misses Q3 EPS by 5c

Applied Genetic Technologies (NASDAQ: AGTC) reported Q3 EPS of ($0.38), $0.05 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $284 thousand versus the consensus estimate of $580 thousand.

For earnings history and earnings-related data on Applied Genetic Technologies (AGTC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c